Annual report [Section 13 and 15(d), not S-K Item 405]

Revenue Recognition (Tables)

v3.26.1
Revenue Recognition (Tables)
12 Months Ended
Dec. 31, 2025
Revenue from Contract with Customer [Abstract]  
Schedule of Revenue by Service Line

Revenue by Service Line

 

 

Year Ended December 31,

 

(in thousands)

 

2025

 

 

2024

 

Biologics and drug delivery

 

 

 

 

 

 

Disposable products

 

$

7,338

 

 

$

5,606

 

Services and license fees

 

 

11,702

 

 

 

11,704

 

Subtotal – Biologics and drug delivery revenue

 

 

19,040

 

 

 

17,310

 

Neurosurgery navigation and therapy

 

 

 

 

 

 

Disposable products

 

 

14,831

 

 

 

10,285

 

Subtotal – Neurosurgery navigation and therapy revenue

 

 

14,831

 

 

 

10,285

 

Capital equipment and software

 

 

 

 

 

 

Systems and software products

 

 

1,690

 

 

 

2,735

 

Services

 

 

1,410

 

 

 

1,060

 

Subtotal – Capital equipment and software revenue

 

 

3,100

 

 

 

3,795

 

Total revenue

 

$

36,971

 

 

$

31,390

 

 

Schedule of Other Current Assets

 

(in thousands)

 

December 31, 2025

 

 

December 31, 2024

 

 

December 31, 2023

 

Accounts receivable, net

 

$

6,549

 

 

$

4,713

 

 

$

3,211

 

Other contract assets

 

 

 

 

 

 

 

 

 

Unbilled receivables

 

$

714

 

 

$

642

 

 

$

733

 

Deferred contract costs

 

$

150

 

 

$

 

 

$

 

Schedule of Revenue Recognized by Contract Liability

(in thousands)

 

December 31, 2025

 

 

December 31, 2024

 

 

December 31, 2023

 

Contract liabilities

 

$

2,250

 

 

$

2,557

 

 

$

3,154